Navigation Links

Biology Technology

MediVet Biologics Acquires Exclusive Patent License from Kansas State University

6/29/2015
Lexington, KY and Manhattan, KS (PRWEB) June 29, 2015 MediVet Biologics today announced that it has acquired US PATENT 7736892 B2. Under the terms of the agreement, MediVet will acquire the rights to a portfolio of cultures, products and methods using Umbilical Cord Matrix Stem Cells (UCMSCs)... [Comments]

Microfluidics Market Growing at 19.3% CAGR To 2020 – New research available at ReportsnReports.com

6/29/2015
(PRWEB) June 29, 2015 The global microfluidics market is expected to grow at a significant CAGR of around 19% during the forecast period (2015 to 2020). The market is mainly driven by the rising geriatric population, growing Asian healthcare market, and upsurge in government and corporate fun... [Comments]

BioNano Mapping Technology Achieves Most Contiguous Clone-free Human Genome Assembly to Date

6/29/2015
SAN DIEGO , June 29, 2015 BioNano Genomics, Inc., the leader in genome mapping, with a group of top research institutes, announced today that a collaboration led by the Icahn School of Medicine at Mount Sinai resulted in the creation of the first comprehensive analysis of a diploid human genome using two complementary single DNA molecule methods for sequencing and genome mappi... [Comments]

AACC's Journal, Clinical Chemistry, Continues to Have Significant Impact on Medical Testing, Healthcare

6/29/2015
WASHINGTON , June 29, 2015  AACC, a global scientific and medical professional organization dedicated to better health through laboratory medicine, is pleased to announce that the impact factor of its journal, Clinical Chemistry , has increased to 7.9 in the 2014 Thomson Reuters Journal Citation Reports. This increase places Clinical Chemistry in the top 3% o... [Comments]

EY Entrepreneur Of The Year Program Recognizes Pete Petit, The Chairman & CEO of MiMedx

6/29/2015
MARIETTA, Ga. , June 29, 2015  MiMedx Group, Inc. (NASDAQ: MDXG ), the leading regenerative medicine company utilizing human amniotic tissue and patent-protected processes to develop and market advanced products and therapies for the Wound Care, Surgical, Orthopedic, Spine, Sports Medicine, Ophthalmic and Dental sectors of healthcare, announced that its Chairman and CEO,... [Comments]

Neuralstem, Inc. Announces Approval for Listing on the NASDAQ Capital Market

6/29/2015
GERMANTOWN, Md. , June 29, 2015  Neuralstem, Inc. (NYSE MKT: CUR), a biopharmaceutical company using neural stem cell technology to develop small molecule and cell therapy treatments for central nervous system diseases, announced today that it has been approved for listing on the NASDAQ Capital Market under the symbol "CUR." The Company's common stock will continue to trad... [Comments]

Aptamers Market Worth $244.93 Million by 2020

6/29/2015
DALLAS , June 29, 2015 According to a new market research report "Aptamers Market by Type (DNA, RNA, XNA), by Application (Diagnostics, Therapeutics, R&D), by Technology (SELEX, Other Technologies), by End Users (Academic Research Institutes, Biotechnology & Pharmaceutical Companies, CRO) - Global Forecast to 2020", published by MarketsandMarkets, the global Aptamers... [Comments]

StampedeCon Announces 2015 Agenda

6/29/2015
St. Louis, MO (PRWEB) June 29, 2015 The StampedeCon 2015 Big Data Conference will be taking place on July 15 – July 16 and for the fourth year in a row, will bring top technology professionals to St. Louis. Top industry speakers will share their insights on what changes are taking place at... [Comments]

Veracyte Named a 2015 "Top Workplace" in the San Francisco Bay Area

6/29/2015
SOUTH SAN FRANCISCO, Calif. , June 29, 2015   Veracyte, Inc . (Nasdaq: VCYT ), a molecular diagnostics company pioneering the field of molecular cytology, today announced that it has been named to the Bay Area News Group's prestigious Top Workplaces list for the second year in a row. The news group selects Top Workplace winners based solely on an annual survey of Bay Area... [Comments]

Results from Digital Maturity Study Show Pharma Lagging

6/29/2015
NEW YORK , June 29, 2015   For the seventh year running, Across Health conducted a survey of life sciences to assess their overall digital maturity called the Multichannel Maturometer . The research continues to show that these companies are not maturing fast enough. While it's true that technology is indeed disrupting the healthcare industry in numerous ways overall... [Comments]

Elsevier Announces 2014 Citation Impact Highlights

6/29/2015
AMSTERDAM , June 29, 2015 Elsevier , a world-leading provider of scientific, technical and medical information products and services, today announced the highlights of its journal Impact Factor performance in 2014. According to the 2014 Journal Citation Reports® (JCR) published by Thomson Reuters, Elsevier saw 55% of its journal Impact Factors increase from 2013 to 201... [Comments]

Medicine Technology

Daktari Honored with IEEE Spectrum Award

6/29/2015
CAMBRIDGE, Mass. , June 29, 2015  Daktari Diagnostics was honored at the 2015 IEEE Spectrum Honors Ceremony with the Technology in the Service of Society Award. IEEE President and CEO, Howard E. Michel , and IEEE President-Elect, Barry L. Shoop presented the award to Principal Scientist Martina Medkova , Ph.D., on behalf of Daktari. The ceremony was held Saturday, Ju... [Comments]

New AHA Guidelines For The Early Management And Treatment Of Stroke Will Change The Standard Of Care For Thousands Of Stroke Patients Each Year

6/29/2015
KALAMAZOO, Mich. , June 29, 2015  New guidelines released today by the American Heart Association and American Stroke Association give hope for better outcomes to the hundreds of thousands of patients who experience an acute ischemic stroke each year. Stryker's Trevo ® Retriever was one of the key products used in the clinical trials that provided data for this devel... [Comments]

PDL BioPharma Announces $40 Million Financing Transaction with CareView Communications

6/29/2015
INCLINE VILLAGE, Nev. , June 29, 2015  PDL BioPharma, Inc. (NASDAQ: PDLI ) today announced that it has entered into a credit agreement with CareView Communications, Inc. (OTCQB: CRVW) whereby PDL will provide CareView with up to $40 million of secured debt financing. CareView is an information technology provider to the healthcare industry focused on patient care monitori... [Comments]

Nevro Appoints Lisa Earnhardt to its Board of Directors

6/29/2015
MENLO PARK, Calif. , June 29, 2015  Nevro Corp. (NYSE: NVRO ), a global medical device company that is providing innovative evidence-based solutions for the treatment of chronic pain, today announced that Lisa Earnhardt , President and Chief Executive Officer of Intersect ENT (NASDAQ: XENT ), has been appointed to its Board of Directors, effective June 28, 2015. For... [Comments]

EnteroMedics Inc. Announces Proposed Public Offering of Common Stock and Warrants

6/29/2015
ST. PAUL, Minn. , June 29, 2015 EnteroMedics Inc. (NASDAQ: ETRM ), a developer and manufacturer of devices that use neuroblocking technology to treat obesity, metabolic diseases, and other gastrointestinal disorders, today announced that it has commenced an underwritten public offering of units. Each unit will consist of a share of common stock, Series A warrants to purchase... [Comments]

BiondVax Presents BVX-006 Preliminary Phase II Results: the Universal Flu Vaccine at Higher Doses is Safe and Improves Immunogenicity in Older Adults

6/29/2015
NESS ZIONA, Israel , June 29, 2015 BiondVax Pharmaceuticals Ltd. (Nasdaq: BVXV, TASE: BVXV) today announced positive preliminary results from its BVX-006 Phase II clinical trial of M-001, BiondVax's candidate for a universal influenza vaccine. In this trial, M-001 was injected intramuscularly to volunteers between the ages of 50 to 65, followed by an administration of th... [Comments]

Allergan to Host Second Quarter 2015 Earnings Conference Call and Webcast

6/29/2015
DUBLIN , June 29, 2015  Allergan plc (NYSE: AGN ) today announced that it intends to release second quarter 2015 financial results on Thursday, August 6, 2015, prior to the open of the U.S. financial markets. The Company will host a conference call and webcast at 8:30 a.m. Eastern Daylight Time on Thursday, August 6, 2015 to discuss its financial results. The di... [Comments]

Alimera Sciences To Present At Cantor Fitzgerald Inaugural Healthcare Conference

6/29/2015
ATLANTA , June 29, 2015  Alimera Sciences, Inc. (NASDAQ: ALIM ) (Alimera), a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced that Rick Eiswirth , Chief Operating Officer and Chief Financial Officer, will present at the 2015 Cantor Fitzgerald Inaugural Healthcare Confere... [Comments]

DURECT to Present at the Cantor Fitzgerald Healthcare Conference

6/29/2015
CUPERTINO, Calif. , June 29, 2015 DURECT Corporation (Nasdaq: DRRX ) announced today that James E. Brown , President and CEO, will be presenting at the Cantor Fitzgerald Healthcare Conference on Wednesday, July 8 at 11:45 a.m. Eastern Time.  The conference is being held at Le Parker Meridien Hotel in New York City.  Investors and analysts that are attending the con... [Comments]

ISIS Pharmaceuticals Promoted to the Large-Cap Russell 1000 Index

6/29/2015
CARLSBAD, Calif. , June 29, 2015  Isis Pharmaceuticals, Inc. (NASDAQ: ISIS ) announced today that it has been added to the Russell 1000 Index, effective June 26, 2015. The Russell 1000 Index measures the performance of the large-cap segment of the U.S. equity universe. It is a subset of the Russell 3000 Index and includes approximately 1000 of the largest securities based... [Comments]

Regeneron Rapid Response Platform for Emerging Infectious Diseases Described in Proceedings of the National Academy of Sciences Publication

6/29/2015
TARRYTOWN, N.Y. , June 29, 2015 Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN ) today announced that the Proceedings of the National Academy of Sciences (PNAS) has published a paper demonstrating that the Company's proprietary VelociGene ® and VelocImmune ® technologies enabled the rapid identification and preclinical validation of potential candidates that coul... [Comments]

(Date:6/29/2015)... , June 29, 2015 ... and medical information products and services, today announced the ... According to the 2014 Journal Citation Reports® (JCR) published ... Impact Factors increase from 2013 to 2014, ahead of ... occupied the top rank in 62 subject categories, up ...
(Date:6/26/2015)... , June 26, 2015   ... ), a pet therapeutics company focused on ... biopharmaceutical products for companion animals, today announced ... study of capromorelin (AT-002), the company,s innovative ... is a small molecule that mimics ghrelin, ...
(Date:6/26/2015)... , ... June 26, 2015 , ... ... of Agriculture (USDA), Grain Inspection, Packers and Stockyards Administration (GIPSA) awarded a five ... vomitoxin in feed and grains utilizing Charm’s ROSA DONQ-FAST5 Test. This 5 minute ...
(Date:6/26/2015)... YORK and MUMBAI, India ... (BSE: 532540, NSE: TCS) a leading global IT services, ... been designated as a Leader in Worldwide Life Sciences ... in the " IDC MarketScape: Worldwide Life Science R&D ... report. The report evaluated eight leading ...
Breaking Biology Technology:Elsevier Announces 2014 Citation Impact Highlights 2Elsevier Announces 2014 Citation Impact Highlights 3Aratana Therapeutics Announces Positive Pivotal Results for AT-002 2Aratana Therapeutics Announces Positive Pivotal Results for AT-002 3Aratana Therapeutics Announces Positive Pivotal Results for AT-002 4Aratana Therapeutics Announces Positive Pivotal Results for AT-002 5USDA-GIPSA (FGIS) Awards 5 Year Contract for Vomitoxin Tests to Charm Sciences 2TCS Recognized as a Leader in Life Sciences R&D Risk-Based Monitoring by IDC MarketScape 2TCS Recognized as a Leader in Life Sciences R&D Risk-Based Monitoring by IDC MarketScape 3TCS Recognized as a Leader in Life Sciences R&D Risk-Based Monitoring by IDC MarketScape 4
... 5, 2012  PharmAthene, Inc. (NYSE Amex: PIP ), ... threats, announced today that management will present at the ROTH ... 2012 at 5:30 pm PT at the Ritz-Carlton Laguna Niguel ... ConferenceDate : , Monday, March 12, 2012 at 5:30 pm ...
... difference between salt water and fresh water is most ... bicarbonate salt solution, Penn State researchers can combine bacterial ... salt-water fresh-water gradient to produce power anywhere. "We ... them together," said Bruce E. Logan, Kappe Professor of ...
... -- FirstMark, the diagnostic division of GenWay Biotech, announced ... was held today on March 1, 2012. The Board ... research. The main focus of the Board will be ... of FirstMark,s new cardiovascular test PREvent. PREvent is the ...
Cached Biology Technology:Unique salt allows energy production to move inland 2Inaugural Meeting of the FirstMark Scientific Board of Advisors 2Inaugural Meeting of the FirstMark Scientific Board of Advisors 3
(Date:6/29/2015)...  Trovagene, Inc. (NASDAQ: TROV ), a developer ... is now included in the Russell 3000®, the Russell ... to the indexes occurred at the close of trading ... its comprehensive set of U.S. and global indexes. ... Cap and Global Indexes coincides with the progress we ...
(Date:6/29/2015)... , June 29, 2015  Relmada Therapeutics, ... therapies for the treatment of chronic pain, announced ... study with novel formulations of oral, enteric-coated buprenorphine ... chronic pain and opioid dependence indications has reached ... company anticipates reporting top-line results in the second ...
(Date:6/29/2015)... England , June 29, 2015  Eli ... Immunocore Limited today announced that they have entered ... the utility of Immunocore,s lead T cell receptor-based ... (LY2157299) and merestinib (LY2801653) for the treatment of ... identify combination regimens that provide synergies in efficacy ...
Breaking Medicine Technology:Trovagene Upgraded to Russell 3000, Small Cap and Global Indexes 2Trovagene Upgraded to Russell 3000, Small Cap and Global Indexes 3Enrollment in Relmada Therapeutics' Proof-of-Concept Clinical Study for Novel Oral Formulations of Buprenorphine Reaches Halfway Mark 2Enrollment in Relmada Therapeutics' Proof-of-Concept Clinical Study for Novel Oral Formulations of Buprenorphine Reaches Halfway Mark 3Lilly and Immunocore Announce Immunotherapy-based Clinical Trial Collaboration in Melanoma 2Lilly and Immunocore Announce Immunotherapy-based Clinical Trial Collaboration in Melanoma 3Lilly and Immunocore Announce Immunotherapy-based Clinical Trial Collaboration in Melanoma 4Lilly and Immunocore Announce Immunotherapy-based Clinical Trial Collaboration in Melanoma 5Lilly and Immunocore Announce Immunotherapy-based Clinical Trial Collaboration in Melanoma 6Lilly and Immunocore Announce Immunotherapy-based Clinical Trial Collaboration in Melanoma 7
... Seating & Mobility (USM) is excited to announce today ... (CKM) to acquire and merge its complex mobility business with ... as central, eastern and southern Kentucky. "The addition ... a core market for us and supports our regional initiative. ...
... Clinical Diagnostics (OCD) today announced the launch of ... that delivers high-quality, reliable test results for mid- ... that drive reliability and efficiency throughout OCD,s portfolio ... x600 Family of Systems, which includes the VITROS® ...
Cached Medicine Technology:Ortho Clinical Diagnostics Launches VITROS® 4600 Chemistry System for Mid- to High-Volume Laboratories 2Ortho Clinical Diagnostics Launches VITROS® 4600 Chemistry System for Mid- to High-Volume Laboratories 3Ortho Clinical Diagnostics Launches VITROS® 4600 Chemistry System for Mid- to High-Volume Laboratories 4